Steady-state pharmacokinetics of midazolam maleate

F. H. Sarnquist, W. D. Mathers, T. F. Blaschke

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.

Original languageEnglish (US)
Pages (from-to)S41
Issue number3 SUPPL
StatePublished - Jan 1 1979

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Steady-state pharmacokinetics of midazolam maleate'. Together they form a unique fingerprint.

Cite this